Top Section/Ad
Top Section/Ad
Most recent
M&A could be much needed shot in the arm but dollars expected to dominate
Deal includes $1bn 3.75 year term loan
The German pharmaceutical wholesaler was upgraded to BBB- by S&P last month
US drug company Eli Lilly jolted the dollar market awake on Wednesday with an eight-part jumbo trade to fund two recent acquisitions
More articles/Ad
More articles/Ad
More articles
-
Rise of mRNA technology was a gamechanger for the sector, says analyst -
Vaccine maker issued shares in oversubscribed deal to fund acquisition
-
-
Existing shareholders took a large chunk of the deal, 30% of bidders left empty-handed
-
Calmer book builds than earlier trades hint at less guesswork over pricing
-
An end-of-year surge in deal-making has sparked predictions of a boom in leveraged buy-outs
